{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:49:14Z","timestamp":1790790554439,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T00:00:00Z","timestamp":1548633600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12933-019-0819-z","type":"journal-article","created":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T08:02:44Z","timestamp":1548662564000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Remnant lipoproteins play an important role of in-stent restenosis in type 2 diabetes undergoing percutaneous coronary intervention: a single-centre observational cohort study"],"prefix":"10.1186","volume":"18","author":[{"given":"Zheng","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-long","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-jun","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-ping","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9545-1984","authenticated-orcid":false,"given":"Yu-jie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,28]]},"reference":[{"key":"819_CR1","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1016\/j.jacc.2010.07.028","volume":"56","author":"GD Dangas","year":"2010","unstructured":"Dangas GD, Claessen BE, Caixeta A, Sanidas EA, Mintz GS, Mehran R. In-stent restenosis in the drug-eluting stent era. J Am Coll Cardiol. 2010;56:1897\u2013907.","journal-title":"J Am Coll Cardiol"},{"key":"819_CR2","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/S0140-6736(07)60314-6","volume":"369","author":"J Daemen","year":"2007","unstructured":"Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet. 2007;369:667\u201378.","journal-title":"Lancet"},{"key":"819_CR3","doi-asserted-by":"publisher","first-page":"e72710","DOI":"10.1371\/journal.pone.0072710","volume":"8","author":"SY Qin","year":"2013","unstructured":"Qin SY, Zhou Y, Jiang HX, Hu BL, Tao L, Xie MZ. The association of diabetes mellitus with clinical outcomes after coronary stenting: a meta-analysis. PLoS ONE. 2013;8:e72710.","journal-title":"PLoS ONE"},{"key":"819_CR4","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12933-017-0609-4","volume":"16","author":"JM Miguel-Yanes De","year":"2017","unstructured":"De Miguel-Yanes JM, Jimenez-Garcia R, Hernandez-Barrera V, Mendez-Bailon M, de Miguel-Diez J, Lopez-de-Andres A. Impact of type 2 diabetes mellitus on in-hospital-mortality after major cardiovascular events in Spain (2002\u20132014). Cardiovasc Diabetol. 2017;16:126.","journal-title":"Cardiovasc Diabetol."},{"key":"819_CR5","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12933-017-0556-0","volume":"16","author":"M Noh","year":"2017","unstructured":"Noh M, Kwon H, Jung CH, Kwon SU, Kim MS, Lee WJ, et al. Impact of diabetes duration and degree of carotid artery stenosis on major adverse cardiovascular events: a single-center, retrospective, observational cohort study. Cardiovasc Diabetol. 2017;16:74.","journal-title":"Cardiovasc Diabetol."},{"key":"819_CR6","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jacl.2015.10.009","volume":"10","author":"L Yan","year":"2016","unstructured":"Yan L, Xu MT, Yuan L, Chen B, Xu ZR, Guo QH, et al. Prevalence of dyslipidemia and its control in type 2 diabetes: a multicenter study in endocrinology clinics of China. J Clin Lipidol. 2016;10:150\u201360.","journal-title":"J Clin Lipidol."},{"key":"819_CR7","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/MCA.0000000000000221","volume":"26","author":"K Zhao","year":"2015","unstructured":"Zhao K, Li YJ, Gao S. Role of red blood cell distribution in predicting drug-eluting stent restenosis in patients with stable angina pectoris after coronary stenting. Coron Artery Dis. 2015;26:220\u20134.","journal-title":"Coron Artery Dis"},{"key":"819_CR8","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1093\/eurheartj\/ehr112","volume":"32","author":"MJ Chapman","year":"2011","unstructured":"Chapman MJ, Ginsberg HN, Amarenco P, Andreotti F, Boren J, Catapano AL, et al. Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management. Eur Heart J. 2011;32:1345\u201361.","journal-title":"Eur Heart J"},{"key":"819_CR9","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1161\/01.CIR.99.22.2858","volume":"99","author":"K Kugiyama","year":"1999","unstructured":"Kugiyama K, Doi H, Takazoe K, Kawano H, Soejima H, Mizuno Y, et al. Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease. Circulation. 1999;99:2858\u201360.","journal-title":"Circulation."},{"key":"819_CR10","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jacl.2015.02.003","volume":"9","author":"TA Jacobson","year":"2015","unstructured":"Jacobson TA, Ito MK, Maki KC, Orringer CE, Bays HE, Jones PH, et al. National lipid association recommendations for patient-centered management of dyslipidemia: part 1-full report. J Clin Lipidol. 2015;9:129\u201369.","journal-title":"J Clin Lipidol."},{"key":"819_CR11","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jacl.2013.12.005","volume":"8","author":"Expert Dyslipidemia Panel of the International Atherosclerosis Society Panel Members","year":"2014","unstructured":"Expert Dyslipidemia Panel of the International Atherosclerosis Society Panel Members. An International atherosclerosis society position paper: global recommendations for the management of dyslipidemia\u2013full report. J Clin Lipidol. 2014;8:29\u201360.","journal-title":"J Clin Lipidol."},{"key":"819_CR12","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1016\/j.jacc.2014.02.545","volume":"63","author":"F Alfonso","year":"2014","unstructured":"Alfonso F, Byrne RA, Rivero F, Kastrati A. Current treatment of in-stent restenosis. J Am Coll Cardiol. 2014;63:2659\u201373.","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl 1","key":"819_CR13","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.2337\/diacare.26.2007.S5","volume":"26","author":"Expert Committee on the Diagnosis and Classification of Diabetes Mellitus","year":"2003","unstructured":"Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003;26(Suppl 1):S5\u201320.","journal-title":"Diabetes Care."},{"key":"819_CR14","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1080\/08037050701461084","volume":"16","author":"G Mansia","year":"2007","unstructured":"Mansia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 ESH-ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European society of hypertension (ESH) and of the European society of cardiology (ESC). Blood Press. 2007;16:135\u2013232.","journal-title":"Blood Press"},{"issue":"Suppl 2","key":"819_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/heartjnl-2014-305693","volume":"100","author":"JB Board","year":"2014","unstructured":"Board JB. Joint British societies\u2019 consensus recommendations for the prevention of cardiovascular disease (JBS3). Heart. 2014;100(Suppl 2):1\u201367.","journal-title":"Heart."},{"key":"819_CR16","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","volume":"376","author":"C Baigent","year":"2010","unstructured":"Baigent C, Blackwell L, Emberson J, Holland LE, Reith C, Bhala N, et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet. 2010;376:1670\u201381.","journal-title":"Lancet"},{"key":"819_CR17","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1093\/qjmed\/hcq165","volume":"104","author":"EJ Mills","year":"2011","unstructured":"Mills EJ, Wu P, Chong G, Ghement I, Singh S, Akl EA, et al. Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170,255 patients from 76 randomized trials. QJM. 2011;104:109\u201324.","journal-title":"QJM"},{"key":"819_CR18","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.pharmthera.2013.11.008","volume":"141","author":"A Varbo","year":"2014","unstructured":"Varbo A, Benn M, Nordestgaard BG. Remnant cholesterol as a cause of ischemic heart disease: evidence, definition, measurement, atherogenicity, high risk patients, and present and future treatment. Pharmacol Ther. 2014;141:358\u201367.","journal-title":"Pharmacol Ther"},{"key":"819_CR19","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ijcard.2009.01.058","volume":"143","author":"R Mitsutake","year":"2010","unstructured":"Mitsutake R, Miura S, Zhang B, Saku K. HDL-associated factors provide additional prognostic information for coronary artery disease as determined by multi-detector row computed tomography. Int J Cardiol. 2010;143:72\u20138.","journal-title":"Int J Cardiol"},{"key":"819_CR20","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1016\/j.jacc.2003.09.074","volume":"43","author":"H Fukushima","year":"2004","unstructured":"Fukushima H, Sugiyama S, Honda O, Koide S, Nakamura S, Sakamoto T, et al. Prognostic value of remnant-like lipoprotein particle levels in patients with coronary artery disease and type II diabetes mellitus. J Am Coll Cardiol. 2004;43:2219\u201324.","journal-title":"J Am Coll Cardiol"},{"key":"819_CR21","doi-asserted-by":"publisher","first-page":"30579","DOI":"10.1074\/jbc.M103761200","volume":"276","author":"D Zhao","year":"2001","unstructured":"Zhao D, Letterman J, Schreiber BM. Beta-migrating very low density lipoprotein (beta VLDL) activates smooth muscle cell mitogen-activated protein (MAP) kinase via G protein-coupled receptor-mediated transactivation of the epidermal growth factor (EGF) receptor: effect of MAP kinase activation on beta VLDL plus EGF-induced cell proliferation. J Biol Chem. 2001;276:30579\u201388.","journal-title":"J Biol Chem"},{"key":"819_CR22","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1161\/01.CIR.0000117403.64398.53","volume":"109","author":"HK Shin","year":"2004","unstructured":"Shin HK, Kim YK, Kim KY, Lee JH, Hong KW. Remnant lipoprotein particles induce apoptosis in endothelial cells by NAD(P)H oxidase-mediated production of superoxide and cytokines via lectin-like oxidized low-density lipoprotein receptor-1 activation: prevention by cilostazol. Circulation. 2004;109:1022\u20138.","journal-title":"Circulation"},{"key":"819_CR23","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.atherosclerosis.2007.12.017","volume":"198","author":"Y Aramaki","year":"2008","unstructured":"Aramaki Y, Mitsuoka H, Toyohara M, Jinnai T, Kanatani K, Nakajima K, et al. Lectin-like oxidized LDL receptor-1 (LOX-1) acts as a receptor for remnant-like lipoprotein particles (RLPs) and mediates RLP-induced migration of vascular smooth muscle cells. Atherosclerosis. 2008;198:272\u20139.","journal-title":"Atherosclerosis."},{"key":"819_CR24","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1124\/jpet.104.077826","volume":"312","author":"SY Park","year":"2005","unstructured":"Park SY, Lee JH, Kim YK, Kim CD, Rhim BY, Lee WS, et al. Cilostazol prevents remnant lipoprotein particle-induced monocyte adhesion to endothelial cells by suppression of adhesion molecules and monocyte chemoattractant protein-1 expression via lectin-like receptor for oxidized low-density lipoprotein receptor activation. J Pharmacol Exp Ther. 2005;312:1241\u20138.","journal-title":"J Pharmacol Exp Ther"},{"key":"819_CR25","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1056\/NEJMoa0908292","volume":"362","author":"W Yang","year":"2010","unstructured":"Yang W, Lu J, Weng J, Jia W, Ji L, Xiao J, et al. Prevalence of diabetes among men and women in China. N Engl J Med. 2010;362:1090\u2013101.","journal-title":"N Engl J Med"},{"key":"819_CR26","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12933-018-0758-0","volume":"17","author":"XF Tang","year":"2018","unstructured":"Tang XF, Ma YL, Song Y, Xu JJ, Yao Y, He C, et al. Biodegradable polymer drug-eluting stents versus second-generation drug-eluting stents in patients with and without diabetes mellitus: a single-center study. Cardiovasc Diabetol. 2018;17:114.","journal-title":"Cardiovasc Diabetol."},{"key":"819_CR27","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12933-017-0606-7","volume":"16","author":"S Tani","year":"2017","unstructured":"Tani S, Yagi T, Atsumi W, Kawauchi K, Matsuo R, Hirayama A. Relation between low-density lipoprotein cholesterol\/apolipoprotein B ratio and triglyceride-rich lipoproteins in patients with coronary artery disease and type 2 diabetes mellitus: a cross-sectional study. Cardiovasc Diabetol. 2017;16:123.","journal-title":"Cardiovasc Diabetol."},{"key":"819_CR28","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12933-018-0738-4","volume":"17","author":"MF Stee van","year":"2018","unstructured":"van Stee MF, de Graaf AA, Groen AK. Actions of metformin and statins on lipid and glucose metabolism and possible benefit of combination therapy. Cardiovasc Diabetol. 2018;17:94.","journal-title":"Cardiovasc Diabetol."},{"key":"819_CR29","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1111\/jdi.12781","volume":"9","author":"S Hattori","year":"2018","unstructured":"Hattori S. Empagliflozin decreases remnant-like particle cholesterol in type 2 diabetes patients with insulin resistance. J Diabetes Investig. 2018;9:870\u20134.","journal-title":"J Diabetes Investig."},{"key":"819_CR30","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12933-017-0602-y","volume":"16","author":"J-C Fruchart","year":"2017","unstructured":"Fruchart J-C. Pemafibrate (K-877), a novel selective peroxisome proliferator-activated receptor alpha modulator for management of atherogenic dyslipidaemia. Cardiovasc Diabetol. 2017;16:124.","journal-title":"Cardiovasc Diabetol."}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-019-0819-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12933-019-0819-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-019-0819-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,11]],"date-time":"2022-09-11T01:07:28Z","timestamp":1662858448000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-019-0819-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,28]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["819"],"URL":"https:\/\/doi.org\/10.1186\/s12933-019-0819-z","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,28]]},"assertion":[{"value":"29 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"11"}}